118 related articles for article (PubMed ID: 38486510)
1. Age-related curves of AMH using the Gen II, the picoAMH and the Elecsys assays in women with polycystic ovary syndrome.
Barbagallo F; van der Ham K; Willemsen SP; Louwers YV; Laven JS
J Clin Endocrinol Metab; 2024 Mar; ():. PubMed ID: 38486510
[TBL] [Abstract][Full Text] [Related]
2. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
4. Validation of an Anti-Müllerian Hormone Cutoff for Polycystic Ovarian Morphology in the Diagnosis of Polycystic Ovary Syndrome in the HARMONIA Study: Protocol for a Prospective, Noninterventional Study.
Piltonen TT; Allegranza D; Hund M; Buck K; Sillman J; Arffman RK
JMIR Res Protoc; 2024 Feb; 13():e48854. PubMed ID: 38319689
[TBL] [Abstract][Full Text] [Related]
5. A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assay.
Welsh P; Smith K; Nelson SM
Hum Reprod; 2014 May; 29(5):1035-41. PubMed ID: 24578473
[TBL] [Abstract][Full Text] [Related]
6. AMH as part of the diagnostic PCOS workup in large epidemiological studies.
Piltonen TT; Komsi E; Morin-Papunen LC; Korhonen E; Franks S; Järvelin MR; Arffman RK; Ollila MM
Eur J Endocrinol; 2023 Jun; 188(6):547-554. PubMed ID: 37294941
[TBL] [Abstract][Full Text] [Related]
7. Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS).
Hoyos LR; Visser JA; McLuskey A; Chazenbalk GD; Grogan TR; Dumesic DA
Hum Reprod; 2020 Oct; 35(10):2294-2302. PubMed ID: 32918081
[TBL] [Abstract][Full Text] [Related]
8. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
[TBL] [Abstract][Full Text] [Related]
9. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
10. Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome.
Evliyaoglu O; Imöhl M; Weiskirchen R; van Helden J
Clin Chem Lab Med; 2020 Jul; 58(8):1291-1301. PubMed ID: 32069226
[TBL] [Abstract][Full Text] [Related]
11. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
Fraissinet A; Robin G; Pigny P; Lefebvre T; Catteau-Jonard S; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1716-1722. PubMed ID: 28854589
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 3 Different AMH Assays With AMH Levels and Follicle Count in Women With Polycystic Ovary Syndrome.
Moolhuijsen LME; Louwers YV; Laven JSE; Visser JA
J Clin Endocrinol Metab; 2022 Aug; 107(9):e3714-e3722. PubMed ID: 35737957
[TBL] [Abstract][Full Text] [Related]
13. The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents.
Khashchenko E; Uvarova E; Vysokikh M; Ivanets T; Krechetova L; Tarasova N; Sukhanova I; Mamedova F; Borovikov P; Balashov I; Sukhikh G
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545404
[TBL] [Abstract][Full Text] [Related]
14. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
[TBL] [Abstract][Full Text] [Related]
15. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.
Calzada M; López N; Noguera JA; Mendiola J; Hernández AI; Corbalán S; Sanchez M; Torres AM
J Obstet Gynaecol; 2019 Nov; 39(8):1130-1136. PubMed ID: 31208261
[TBL] [Abstract][Full Text] [Related]
16. Antimüllerian hormone to determine polycystic ovarian morphology.
Dietz de Loos A; Hund M; Buck K; Meun C; Sillman J; Laven JSE
Fertil Steril; 2021 Oct; 116(4):1149-1157. PubMed ID: 34579824
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of three new commercial immunoassays for anti-Müllerian hormone measurement.
Li HW; Wong BP; Ip WK; Yeung WS; Ho PC; Ng EH
Hum Reprod; 2016 Dec; 31(12):2796-2802. PubMed ID: 27702835
[TBL] [Abstract][Full Text] [Related]
18. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
19. Revisiting the serum level of anti-Müllerian hormone in patients with functional hypothalamic anovulation.
Makolle S; Catteau-Jonard S; Robin G; Dewailly D
Hum Reprod; 2021 Mar; 36(4):1043-1051. PubMed ID: 33580689
[TBL] [Abstract][Full Text] [Related]
20. Determining the age group-based cut-off values of serum anti-Mullerian hormone concentrations to diagnose polycystic ovary syndrome.
Timur HT; Cimrin D; Gursoy Doruk O; Dogan OE
Curr Med Res Opin; 2023 Jun; 39(6):855-863. PubMed ID: 37074782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
